Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 8 relevant journals, 13 Conferences, 28workshops are presently dedicated exclusively to Pain medicine list and about 582 articles are being published on pain medicine list.
Pain can either be managed using pharmacological or interventional procedures. There are many interventional procedures available for pain. Interventional procedures - typically used for chronic back pain - include epidural steroid injections, facet joint injections, neurolytic blocks, spinal cord stimulators and intrathecal drug delivery system implants. Pain management practitioners come from all fields of medicine in addition to that we need to know physical and physiological approaches in pain management, Novel therapeutic approaches.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The World Institute of Pain (WIP), a worldwide organization founded in 1993, offers a fellowship program utilizing a global forum for education, training and networking to qualified physicians in the field of Pain Medicine. In 2001, the WIP and its FIPP Board of Exam introduced the Fellow of Interventional Pain Practice (FIPP), a physician certification program by the FIPP Board of Examination. According to WIP, the purpose of the fellowship is global advancement and standardization of interventional pain practice. Over eight-hundred physicians from fifty different countries have been FIPP certified.
Although the analgesia market is highly competitive and heavily genericized, growth is expected. Improved diagnosis of fibromyalgia and neuropathic pain will be key driving factors. Sales of pain therapeutics could reach a massive $59 billion by 2015 in the seven major markets.Biomarkers will transform pain R&D away from the traditional linear, over-simplified model approach. Novel analgesia drug targets will be realized, streamlining clinical trials and optimizing candidate’s efficacy and safety profiles.Opioids will continue to form the backbone of pain relief due to improved physician prescribing confidence. By 2015, sales of opioids could reach $17 billion, with OxyContin (oxycodone; Purdue) remaining the top-selling branded analgesic until its patent expiration in 2013.
International symposium and workshops
List of Best International Conferences:
This page will be updated regularly.
This page was last updated on November 27, 2020